IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 121 filers reported holding IVERIC BIO INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $271 | -99.9% | 12,734 | -77.7% | 0.00% | -50.0% |
| Q4 2020 | $394,000 | -86.3% | 56,980 | -88.9% | 0.00% | -83.3% |
| Q3 2020 | $2,886,000 | -40.3% | 511,725 | -46.0% | 0.01% | -42.9% |
| Q2 2020 | $4,836,000 | +54.6% | 948,292 | +4.3% | 0.02% | +16.7% |
| Q1 2020 | $3,128,000 | -59.0% | 909,376 | +2.2% | 0.02% | -48.6% |
| Q4 2019 | $7,633,000 | +449.5% | 889,544 | -28.3% | 0.04% | +483.3% |
| Q3 2019 | $1,389,000 | -15.1% | 1,240,327 | -1.6% | 0.01% | -25.0% |
| Q2 2019 | $1,636,000 | – | 1,260,405 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |